Supplier

Amgen Ltd

Value won

£856.1m

Across 3 contracts won

A United Kingdom supplier, with 3 awarded contracts, totalling £856.1m, most recently 2 months ago.

United Kingdom(inferred)

Value won

£856.1m

Across 3 contracts won

Contract history

3 entries

Most recent
15 Jun 2026
2 months ago
Biggest
£832.8m
NHS Branded Medicines Framework - T…
Average size
£285.4m
Across 3 priced
Last 12 months
3
entries

Won · 3

Ustekinumab Supply£6,532,463 · 15 Jun 2026 NHS Branded Medicines Framework - Tranche B (London & South of England)£832,766,796 · 9 Jun 2026 Supply of Transitional Drugs 7£16,804,001 · 5 Jun 2026

Apr 26May 26Jun 26Jul 26Jul 26

Opportunities

Showing awarded · 4

AwardedHealthcare & MedicalUnited Kingdom

NHS Framework Agreement for Branded Medicines - North, Midlands, East, and London Regions

NHS is establishing a branded medicines framework agreement across English regions, with two separate lots for different geographical areas and contract durations starting September 2026.

£201,659,945NHS ENGLAND

Published 23 Jun 2026

AwardedHealthcare & MedicalUnited Kingdom

Ustekinumab Supply

Opportunity to supply Ustekinumab, an immunosuppressant biopharmaceutical medication for various therapeutic applications.

£6,532,463NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Published 15 Jun 2026

AwardedHealthcare & MedicalUnited Kingdom

NHS Branded Medicines Framework - Tranche B (London & South of England)

NHS is seeking suppliers for branded medicines across England in two regional lots, with framework agreements commencing September 2026.

£832,766,796NHS ENGLAND

Published 9 Jun 2026

AwardedHealthcare & MedicalUnited Kingdom

Supply of Transitional Drugs 7

Procurement for the supply of Transitional Drugs 7 from qualified pharmaceutical vendors.

£16,804,001NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Published 5 Jun 2026